Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model—a study based on data from an international multicentre project (EPCRC-CSA)

Blum, D. ; Stene, G. B. ; Solheim, T. S. ; Fayers, P. ; Hjermstad, M. J. ; Baracos, V. E. ; Fearon, K. ; Strasser, F. ; Kaasa, S. ; Block Lieve, Van den ; Koen, Meeussen ; Sarah, Brearley ; Augusto, Caraceni ; Joachim, Cohen ; Massimo, Costantini ; Anneke, Francke ; Richard, Harding ; Higginson Irene, J. ; Stein, Kaasa ; Karen, Linden ; Guido, Miccinesi ; Bregje, Onwuteaka-Philipsen ; Koen, Pardon ; Roeline, Pasman ; Sophie, Pautex ; Sheila, Payne ; Luc, Deliens

In: Annals of Oncology, 2014, vol. 25, no. 8, p. 1635-1642

Ajouter à la liste personnelle
    Summary
    A cancer cachexia classification into stages is warranted in order to guide treatment decisions and clinical trial inclusion. Weight loss and BMI clearly discriminate between non-cachectic and cachectic patients both with regards to all the domains (Intake, Catabolism and Function) and survival. The precachexia stage might be better defined by additional factors in order to be discriminative